Switch to:

Key Ratios

New Key Statistics Module, Z-Score and F-Score
Market Cap $M4,514Revenue $M287Net Margin (%)-26.6Z-Score9.3
Enterprise Value $M4,174EPS $-0.6Operating Margin %-27.0F-Score4
P/E(ttm))0Cash Flow Per Share $-1.2Pre-tax Margin (%)-26.6Higher ROA y-yY
Price/Book21.510-y EBITDA Growth Rate %-4.5Quick Ratio4.2Cash flow > EarningsY
Price/Sales16.15-y EBITDA Growth Rate %-16.3Current Ratio4.8Lower Leverage y-yY
Price/Cash Flow0y-y EBITDA Growth Rate %0ROA % (ttm)-16.1Higher Current Ratio y-yY
Dividend Yield %0Insider Buy (3m)1ROE % (ttm)-33.9Less Shares Outstanding y-yN
Payout Ratio %0Shares Outstanding M124ROI % (ttm)-20.8Gross Margin Increase y-yN

Gurus Latest Trades with SGEN

Number of guru portfolios checked: 85. (List those with share number changes of more than 20%, or impact to portfolio more than 0.1%)
TickerGuruDate Action
Impactdown Price Range
(Average)*
Current Price Change from Average Comment Current Shares
SGENRay Dalio 2014-12-31 Sold Out $31.1 - $37.8
($34.88)
$ 36.635%Sold Out0
SGENRay Dalio 2014-09-30 Buy $33.75 - $44.14
($39.36)
$ 36.63-7%New holding, 6140 sh.6,140
SGENRay Dalio 2014-06-30 Sold Out -0.01%$32.82 - $46.79
($37.8)
$ 36.63-3%Sold Out0
SGENRay Dalio 2014-03-31 Buy 0.01%$38.57 - $55.14
($47.61)
$ 36.63-23%New holding, 22400 sh.22,400
SGENPRIMECAP Management 2011-06-30 Add0.05%$15 - $21.34
($17.98)
$ 36.63104%Add 21.21%9,572,853
SGENPRIMECAP Management 2011-03-31 Add0.04%$13.95 - $17.23
($15.41)
$ 36.63138%Add 29.25%7,897,953
SGENPRIMECAP Management 2010-12-31 Add0.06%$13.77 - $17.35
($15.64)
$ 36.63134%Add 77.8%6,110,600
SGENPRIMECAP Management 2010-09-30 Buy 0.09%$11.44 - $15.08
($12.22)
$ 36.63200%New holding, 3436800 sh.3,436,800
SGENJean-Marie Eveillard 2010-03-31 Sold Out -0.01%$9.34 - $12.59
($10.84)
$ 36.63238%Sold Out0
SGENJean-Marie Eveillard 2009-12-31 Buy 0.01%$8.74 - $13.16
($9.69)
$ 36.63278%New holding, 67373 sh.67,373
SGENBill Gates 2009-09-30 Sold Out -0.39%$8.75 - $14.8
($11.69)
$ 36.63213%Sold Out0
SGENJean-Marie Eveillard 2009-06-30 Sold Out -0.01%$8.18 - $10.34
($9.08)
$ 36.63303%Sold Out0
SGENJean-Marie Eveillard 2009-03-31 Add$7.23 - $10.36
($9.4)
$ 36.63290%Add 40%70,000
SGENJean-Marie Eveillard 2008-12-31 Buy 0.01%$7.76 - $10.6
($8.9)
$ 36.63312%New holding, 50000 sh.50,000
SGENJean-Marie Eveillard 2008-09-30 Sold Out $8.23 - $12.97
($11)
$ 36.63233%Sold Out0
SGENJean-Marie Eveillard 2008-06-30 Buy $8.79 - $10.59
($9.6)
$ 36.63282%New holding, 60000 sh.60,000
SGENJean-Marie Eveillard 2007-06-30 Sold Out -0.01%$8.48 - $10.41
($9.7)
$ 36.63278%Sold Out0
Premium Real Time Picks are included for Premium Members only!!
*The price and date might not be the actual time and price at which the transactions were made. In the case of institutional owners, the date is stated as the last day of their fiscal quarter. The prices are estimates if no accurate information available. Foreign holdings may not be included.

SGEN is held by these Gurus:

Ticker Guru Name Portfolio Date* Current Shares % of Shares Outstanding % of Total Assets Managed Change from Last Holdings Holding History
SGEN PRIMECAP Management 2014-12-3111,178,0509.020.36+2.04%
SGEN Ray Dalio 2014-12-31000Sold Out
Premium Most recent portfolio changes are included for Premium Members only!


SGEN: Insider Buys/Sells

Click Here for All Insider Trades.
InsiderPosition Date Trades Shares Trade Price ($) Change (%) Details
SIEGALL CLAY BPresident and CEO 2015-01-06Sell16,804$31.815.19view
BAKER FELIXDirector, 10% Owner 2014-12-16Buy2,883,378$31.8614.97view
BAKER FELIXDirector, 10% Owner 2014-12-10Buy1,247,896$33.828.31view
FBB3 LLCDirector, 10% Owner 2014-12-09Sell0$08.31view
HIMES VAUGHN BEVP, Tech. Ops. & Proc. Sci. 2014-11-12Sell10,000$37.52-2.37view
BAKER FELIXDirector, 10% Owner 2014-11-10Buy1,653,925$34.565.99view
SIEGALL CLAY BPresident and CEO 2014-09-04Sell5,600$42.54-13.89view
DOBMEIER ERICCOO 2014-08-25Sell4,818$43.55-15.89view
SIMPSON TODD ECFO 2014-08-24Sell3,696$43.55-15.89view
SIEGALL CLAY BPresident and CEO 2014-08-24Sell25,507$43.55-15.89view

Press Releases about SGEN :

    Quarterly/Annual Reports about SGEN:

      News about SGEN:

      Articles On GuruFocus.com
      Seattle Genetics: Can Record Growth From Its Licenses Oct 28 2014 
      Seattle Genetics: Can Record Sustained Growth From Royalty Aug 31 2014 
      Will ImmunoGen’s Q4 Earnings Disappoint Again? Jul 30 2014 
      Weekly CFO Sells Highlight: USB, SGEN, CAH, ALXN, ABMD Jul 21 2013 
      Comment for Companies Ranked by Business Predictability Jan 03 2013 
      Weekly CFO Sells Highlight: SGEN, PFIE, MAR, ESRX, LIOX, RGEN Sep 10 2012 
      WEEKLY CFO SELLS HIGHLIGHT: SBAC, XOXO, MTH, FICO, SGEN, OAS Sep 03 2012 
      Weekly CFO Sells Highlight: SWKS, P, SGEN, RT Jun 11 2012 
      5 Resilient Biotech Stocks to Buy for 2012 Feb 28 2012 
      Weekly CFO Sells Highlight: SGEN, APKT, AMRC, FNGN Oct 10 2011 


      More From Other Websites
      Seattle Genetics to Present at Upcoming Investor Conferences Feb 25 2015
      Seattle Genetics (SGEN) Filed Supplemental BLA for Adcetris - Analyst Blog Feb 19 2015
      Seattle Genetics' SEA-CD40 Enters Phase I for Solid Tumors - Analyst Blog Feb 18 2015
      Seattle Genetics Submits Supplemental BLA to FDA for Phase 3 AETHERA Trial of ADCETRIS®... Feb 18 2015
      Seattle Genetics Submits Supplemental BLA to FDA for Phase 3 AETHERA Trial of ADCETRIS®... Feb 18 2015
      Seattle Genetics Advances Immuno-Oncology Program SEA-CD40 Into Phase 1 Clinical Trial for Advanced... Feb 17 2015
      Seattle Genetics Advances Immuno-Oncology Program SEA-CD40 Into Phase 1 Clinical Trial for Advanced... Feb 17 2015
      Ceiling seen for Seattle Genetics Feb 12 2015
      Seattle Genetics Posts Narrower-than-Expected Loss in Q4 - Analyst Blog Feb 11 2015
      Seattle Genetics reports 4Q loss Feb 10 2015
      Seattle Genetics reports 4Q loss Feb 10 2015
      Seattle Genetics Inc Earnings Call scheduled for 4:30 pm ET today Feb 10 2015
      SEATTLE GENETICS INC /WA Files SEC form 8-K, Results of Operations and Financial Condition,... Feb 10 2015
      Seattle Genetics Reports Fourth Quarter and Year 2014 Financial Results Feb 10 2015
      Q4 2014 Seattle Genetics Inc Earnings Release - After Market Close Feb 10 2015
      SEATTLE GENETICS INC /WA Files SEC form 8-K, Change in Directors or Principal Officers, Financial... Feb 06 2015
      Seattle Genetics to Present at Leerink Global Healthcare Conference Feb 05 2015
      Seattle Genetics to Present at Leerink Global Healthcare Conference Feb 05 2015
      Immunomedics Shares Slip Despite Encouraging Data on ADC Cancer Therapy Jan 22 2015
      Seattle Genetics to Host Conference Call and Webcast Discussion of Fourth Quarter and Year 2014... Jan 21 2015

      Add Notes, Comments

      If you want to ask a question, or report a bug, please create a support ticket.

      User Comments

      No comment yet
      Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
      GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)
      Free 7-day Trial
      FEEDBACK